StraightGait

Biofeedback Orthotics

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in January 2017 by Raphi Blustein, StraightGait operates with 1-10 employees. The company is currently in a Pre-Funding stage and has developed a patented device for gait correction. In July 2018, StraightGait participated in the AtoBe accelerator program, graduating in January 2019.

Business overview

StraightGait specializes in designing, patenting, and marketing paramedical and sports devices, particularly foot orthotics with integrated biofeedback alerts. The company focuses on developing technology to help individuals suffering from internal tibial torsion (in-toeing or out-toeing) correct their gait. Its core product is a device that provides real-time alerts to patients when they are walking incorrectly, serving the Health Tech & Life Sciences sector, specifically targeting medical devices and assistive devices for consumers, including children, as well as healthcare providers and patients.

Log in to access full profile

Company Intelligence Q&A

What is StraightGait's primary focus?
StraightGait designs, patents, and markets paramedical and sports devices, specifically foot orthotics with integrated biofeedback alerts, to correct gait issues like in-toeing or out-toeing.
Who founded StraightGait and when?
StraightGait was founded in January 2017 by Raphi Blustein.
What kind of technology does StraightGait use?
StraightGait utilizes integrated biofeedback alerts and related methods within its orthotic devices to provide real-time feedback for gait correction.
Which accelerator program did StraightGait participate in?
StraightGait participated in the AtoBe accelerator program, joining in July 2018 and graduating in January 2019.
What is the current stage of StraightGait's product development?
StraightGait's product, StraightGait POC, is currently in the Beta stage. The company has developed a patented device for gait correction and is actively working on its further development and market introduction.
Log in to access full profile